Agilent Technologies, Inc. $A Stake Lessened by Cinctive Capital Management LP

Cinctive Capital Management LP cut its stake in Agilent Technologies, Inc. (NYSE:A) by 12.3% during the 3rd quarter, HoldingsChannel reports. The fund owned 72,856 shares of the medical research company’s stock after selling 10,196 shares during the period. Cinctive Capital Management LP’s holdings in Agilent Technologies were worth $9,351,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the stock. Capital A Wealth Management LLC boosted its stake in Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 212 shares during the last quarter. Davis Capital Management bought a new stake in shares of Agilent Technologies in the 3rd quarter worth about $28,000. Physician Wealth Advisors Inc. raised its stake in shares of Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 196 shares in the last quarter. State of Wyoming acquired a new stake in shares of Agilent Technologies in the 2nd quarter valued at about $35,000. Finally, SJS Investment Consulting Inc. lifted its position in shares of Agilent Technologies by 2,836.4% during the third quarter. SJS Investment Consulting Inc. now owns 323 shares of the medical research company’s stock worth $41,000 after purchasing an additional 312 shares during the last quarter. 87.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A has been the subject of a number of research reports. Bank of America lifted their price target on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price objective for the company from $155.00 to $160.00 in a research note on Monday, January 5th. TD Cowen reduced their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Wells Fargo & Company decreased their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Finally, UBS Group lowered their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $161.20.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $111.60 on Friday. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The firm has a 50-day simple moving average of $130.34 and a 200 day simple moving average of $135.83. The company has a market cap of $31.54 billion, a PE ratio of 24.64, a P/E/G ratio of 2.35 and a beta of 1.31.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. During the same quarter last year, the company earned $1.31 EPS. Agilent Technologies’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.